相关实验视频

Updated: Mar 15, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Sarcoma 中瘤血栓的儿科患者的低生存率

Michael J Colello¹, Annika Y Myers¹, Abigail N Padilla¹

¹Children's Hospital Los Angeles, Los Angeles, CA 90027, USA.

Journal of clinical medicine

|March 14, 2026

概括

患有瘤血栓的儿科肉瘤的预后不好,诊断后的总体存活率约为30%. 在这项研究中,手术干预并没有显著改善长期生存率.

科学领域:

儿科瘤学儿科瘤学
手术病理学手术病理学
放射学放射学是一门学科.

背景情况:

在肉瘤中瘤血栓很少见,特别是在儿童中,结果不明.
成人的数据表明,平均存活时间约为14个月,但儿科数据有限.

研究的目的:

为了研究患有瘤血栓的儿科肉瘤患者的结果.
了解这个特定患者群体的预后因素和生存率.

主要方法:

儿科患者 (<18岁) 的回顾性审查,确认了瘤和瘤血栓.
从1990年到2025年在一个儿科三级中心收集的数据.
至少3年的随访或直到生命结束,专注于生存后瘤血栓诊断.

主要成果:

包括13名儿科患者 (平均年龄10.5岁);骨髓瘤是最常见的亚型.
瘤血栓诊断后的整体存活率为30.8%,诊断后的中位生存时间为15.2个月.
瘤血栓在38.5%的病例中是非连续的,突出显示了需要先进的成像.

结论:

患有瘤血栓的儿科肉瘤的预后不好.
在这个队列中,手术干预没有显示出长期生存益处.
非连续性瘤血栓需要在治疗计划和患者咨询中仔细考虑.

关键词:

骨质肉瘤是骨质肉瘤的一种疾病.肉瘤肉瘤是一种肉瘤.幸存率幸存率生存率瘤的血栓,瘤的血栓

更多相关视频

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

相关概念视频

Pharmacokinetics in Pediatric Patients: Drug Distribution

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...